Director, Texas Children’s Cancer and Hematology Centers
Elise C. Young Professor of Pediatric Oncology
Department of Pediatrics,
Baylor College of Medicine
Texas Children’s Hospital
Dan L. Duncan Cancer Center
Baylor College of Medicine
Dr. David Poplack
Texas Children’s Cancer Center
1102 Bates Street, Suite 1570
Houston, TX 77030
Dr. David Poplack is the Director of the Texas Children’s Cancer and Hematology Centers; Deputy Director of Baylor College of Medicine’s (BCM’s) Dan L. Duncan Cancer Center; Section Head, Hematology/Oncology, Department of Pediatrics, BCM; Hematology/Oncology Service Chief, Texas Children’s Hospital; and is the Elise C. Young Professor of Pediatric Oncology.
Dr. Poplack is Principal Investigator of an NCI K12 Pediatric Oncology Clinical Research Training Grant. Dr. Poplack has authored 357 original articles and book chapters relating to pediatric oncology and serves on the editorial board of numerous subspecialty journals. He is co-editor of Principles and Practice of Pediatric Oncology, the leading textbook of pediatric oncology, which is in its sixth edition. He has also served on numerous NIH, FDA and Institute of Medicine Committees. Dr. Poplack is a member of the National Cancer Institutes’ Board of Scientific Counselors.
M.D., Boston University School of Medicine
Internship, Stanford University Hospital
Residency, Children’s Hospital Medical Center, Boston
Fellowship, National Cancer Institute
Diplomate, American Board of Pediatrics
Certified Sub-specialty, American Board of Pediatrics — Hematology/Oncology
American Association for the Advancement of Science (AAAS)
American Association for Cancer Research (AACR)
American Medical Association (AMA)
American Society for Clinical Investigation (ASCI)
American Society of Clinical Oncology (ASCO)
American Society of Hematology (ASH)
International Society of Paediatric Oncology (SIOP)
Texas Medical Association (TMA)
Pizzo PA, Poplack DG: Principles and Practice of Pediatric Oncology (Fifth edition) Philadelphia, PA: Lippincott Williams & Wilkins, 2005.
Blaney SM, Heideman, R., Berg S, Adamson P, Gillespie A, Geyer JR, Packer R, Matthay K, Jaeckle K, Cole D, Kuttesch N, Poplack DG, Balis FM. Phase I clinical trial of Intrathecal Topetecan in patients with neoplastic meningitis. Journal of Clinical Oncology 2003, 21: 143-147.
Margolin, JF and Poplack, DG. Review of article “What is the optimal therapy for childhood AML? Oncology 2002, 1069-1070.
Steuber CP and Poplack DG. Acute Lymphoblastic Leukemia. In Rudolph CD, Rudolph AM, Hostetter MK, Lister G, Siegel NJ (eds). Rudolph’s Pediatrics, 21st Edition. New York. McGraw-Hill Medical Publishing Division, pp. 1594-1600, 2002.
Bomgaars L, Chamberlain MC, Poplack DG and Blaney M. Leptomeningeal metastases. In Levin VA (ed). Cancer in the Nervous System, Second Edition. New York. Oxford University Press, pp. 375-396, 2002.